Transparency
Market Research (TMR) delivers key insights on the global Medical
Nutrition market in its upcoming outlook titled, “Medical Nutrition
Market: Global Industry Analysis, Size, Share, Growth, Trends and
Forecast 2018-2026”. In terms of value, the global medical
nutrition market is projected to register a healthy CAGR of 6.2%
during the forecast period due to various factors, regarding which
TMR offers vital insights in detail.
The
increasing aging population is now recognized as a global issue of
importance. Changes in lifestyle have resulted in rapid aging amongst
the population, increasing the prevalence of various diseases. The
total aging population (over 65 years) has increased from 9.2% in
1990 to 11.7% in 2013. The number of older individuals is expected to
grow from 841 Mn in 2013 to more than 2 Bn in 2050, as per the World
Population Report.
Request
A Sample Of Medical Nutrition Market -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1704
Around
two-thirds of general and acute hospital beds are used by the
geriatric population over 65 years, and people over 75 years old have
longer stays. The burden of the geriatric population influences the
demand and supply of nutritional food to this population and is a
major contributor to the medical nutrition market. The prevalence of
malnutrition in Europe and North America is 1-15% in non-
institutionalized elder population, 25-60% for older adults in
geriatric care facilities, and 35-60% in older adults in hospitals
according medical research sources. The rising use of home parenteral
medical nutrition therapy by the geriatric population with chronic
illnesses such as diabetes, cancer, and AIDS is anticipated to boost
market growth. Furthermore, the geriatric population is more prone to
diseases such as nervous disorders, Parkinson’s, diabetes, and
organ system failure. Such patients suffer from restrictive food
ingestion, and require parenteral medical nutrition feeding to
maintain their nutritional levels.
Parenteral
medical nutrition administration demands regular assessment and
monitoring in order to avoid complications or side effects.
Inappropriate usage of this medical nutrition maximizes the potential
risk of adverse events such as re-feeding syndrome, particulate
contamination, catheter infections, and liver dysfunction for the
patients undergoing the medical nutrition therapy. Catheter-related
bloodstream infection (CRBSI) is a grave complication among patients
and requires frequent and expensive parenteral medical nutrition
therapy. An article published by the American Society for Nutrition
in 2014 also indicated that, long-term parenteral medical
nutrition therapy significantly increases the risk of liver
disease and metabolic complications in patients. Another study
published by the University Health Network also states about the
complications arising in the home parenteral medical nutrition
therapy while treating the metabolic bone disease in patients.
Moreover, problems such as allergic reactions, shortness of breath,
unexplained weight gain, muscle pain, weakness, and loss of appetite
are more common among patients undergoing parenteral medical
nutrition therapy. These complications/side-effects are expected to
restrain the medical nutrition market growth.
This
report covers trends driving each segment and offers analysis and
insights of the potential of the medical nutrition market in specific
regions. North America is expected to register high growth rates
between 2018 and 2026 and is also expected to remain the largest
market through 2026. According to market attractiveness, North
America and Europe are a relative more attractive markets in the
medical nutrition market. On the basis of product type, the medical
nutrition market is segmented as standard formula and specialized
formula. Other segments include flavor, indication, distribution
channel and end user. The indication segment is further sub segmented
as enteral and parenteral nutrition.
Detailed
profiles of the providers are also included in the scope of the
report to evaluate their long-term and short-term strategies, key
offerings and recent developments in the medical nutrition space.
Medical Nutrition key players include NUTRICIÓN MÉDICA SL, Meiji
Holdings Co., Ltd., Medtrition Inc., Baxter International Inc., B.
Braun Melsungen AG., Fresenius Kabi AG, Danone Nutricia, Nestlé
S.A., LLC, Otsuka Holdings Co., Ltd. (Parent of Otsuka
Pharmaceutical)Europe Ltd. and Abbott Laboratories amongst others.
No comments:
Post a Comment